Australia's NeuroScientific Biopharmaceuticals soars on buying biotech co

Neuroscientific Biopharmaceuticals

16/04/2025 05:43

** NeuroScientific Biopharmaceuticals NSB.AX surges 77.1% to A$0.062, highest since April 11, 2024

** Pharma firm says it will buy private co Isopogen WA for its patented stem cell tech to manufacture cellular medicine mesenchymal stromal cells

** Raises A$3.5 mln ($2.2 mln) at issue price of A$0.035

** Stock sees busiest session since April 2024, with about 8.2 mln shares traded - 96.6x the 30-day avg

** NSB up 78.8% YTD

($1 = A$1.5773)

 (Reporting by Jasmeen Ara Shaikh in Bengaluru)

 ((JasmeenAraIslam.Shaikh@thomsonreuters.com;))